MedTrace Logo

Clinical Study for Patients With Hypertension Associated With Dyslipidemia

NCT01764295 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2013-08-23

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of DWJ1276

Conditions

Interventions

DRUG

DWJ1276

DRUG

Olmesartan

DRUG

Rosuvastatin

DRUG

Placebo

Sponsors & Collaborators

  • Daewoong Pharmaceutical Co. LTD.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
FACTORIAL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2013-05-31
Completion
2013-07-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01764295 on ClinicalTrials.gov